Mirna Therapeutics, Inc. (Mirna)

Oncology Corporate Profile

HQ Location

2150 Woodward St., Suite 100
Austin, TX 78744

Company Description

Mirna Therapeutics, Inc. (Mirna) is a private biotechnology company focused on the development and commercialization of microRNA (miRNA) based therapeutics. In 2013, the Company was the first to launch a clinical trial of a miRNA mimic drug candidate for the treatment of cancer. Mirna's intellectual property portfolio contains numerous issued patents and patent applications, pertaining to more than 300 miRNAs with applications in oncology and other diseases. Oncology-directed miRNAs include key tumor suppressors in cancer, such as miR-34 and let-7, which inhibited tumor growth in a number of preclinical studies.

Website: http://www.mirnarx.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
MRX34microRNAHepatocellular carcinoma (HCC)I
MRX34microRNAVarious cancer typesI

View additional information on product candidates here »

Source: http://www.mirnarx.com

Recent News Headlines

There are no news items to display